Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Curcumin. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102911022A details a boron-mediated synthesis of curcuminoids offering high purity >98% and simplified downstream processing for pharmaceutical supply chains.
Patent CN103012175A details water-soluble curcumin salts. Enhances stability and bioavailability for pharmaceutical manufacturing.
Novel two-step synthesis improves yield and purity for curcumin derivatives. Reduces toxic solvent use and simplifies purification for reliable pharmaceutical intermediates supply chains.
Patent CN113322219A reveals high-efficiency biocatalytic route for curcumin glucosides offering enhanced solubility and scalable production for pharmaceutical and food industries
Advanced synthesis route from bisdemethoxycurcumin ensures high purity and scalable production for pharmaceutical intermediates and commercial supply chains.
Patent CN108101761A details a boron-free curcumin synthesis. This report analyzes cost reduction and supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN102503842B details amino alkoxy curcumin derivatives enhancing solubility and anti-tumor activity for cost reduction in pharmaceutical intermediates manufacturing.
Patent CN102503842A details novel aminoalkoxy curcumin derivatives with enhanced anticancer activity. Discover scalable synthesis routes for high-purity pharmaceutical intermediates.
Patent CN104557558B reveals stable nitro-curcumin derivatives with superior anti-inflammatory activity. Scalable aldol condensation process ensures cost-effective supply chain solutions.
Patent CN112374976B details a 3-step route to (1E,4E)-1,5-bis(2-methoxyphenyl)pent-1,4-dien-3-one avoiding heavy metals and column chromatography for cost-effective manufacturing.
Novel DMAP-catalyzed esterification patent CN108424383A offers high yield 89.4%. Reliable curcumin nicotinate supplier ensuring cost reduction and supply continuity.
Patent CN111116339B reveals a novel acidic boron-complex route for curcumin. Achieve 90% yields with reduced waste. Ideal for reliable curcumin supplier partnerships.
Novel tertiary amine-thiourea catalyst enables high-yield asymmetric conjugate addition for scalable API intermediate production with superior enantioselectivity.
Solve ASC-J9 supply chain challenges with 95% yield, 98.6% purity, and 3h reaction time. CDMO expertise for pharma scale.